Selective internal radiation therapy (SIRT) in primary or secondary liver cancer

Autor: Prompers, L., Bucerius, J., Brans, B., Temur, Y., Berger, L., Mottaghy, Felix M.

Publikováno v: In Methods 2011 55(3):253-257

Clinical radionuclide therapy dosimetry: the quest for the “Holy Gray”.

Autor: Brans, B.¹ b.brans@lnug.azm.nl, Bodei, L.², Giammarile, F.³, Linden, O.⁴, Luster, M.⁵, Oyen, W. J. G.⁶, Tennvall, J.⁴

Publikováno v: European Journal of Nuclear Medicine & Molecular Imaging. May2007, Vol. 34 Issue 5, p772-786. 15p. 2 Charts, 1 Graph.

Targeted therapy in nuclear medicine—current status and future prospects

Autor: Oyen, W. J. G., Bodei, L., Giammarile, F., Maecke, H. R., Tennvall, J., Luster, M., Brans, B.

Publikováno v: Oyen, W. J. G.; Bodei, L.; Giammarile, F.; Maecke, H. R.; Tennvall, J.; Luster, M.; Brans, B. (2007). Targeted therapy in nuclear medicine—current status and future prospects. Annals of oncology, 18(11), pp. 1782-1792. Oxford University Press 10.1093/annonc/mdm111

In recent years, a number of new developments in targeted therapies using radiolabeled compounds have emerged. New developments and insights in radioiodine treatment of thyroid cancer, treatment of lymphoma and solid tumors with radiolabeled monoclon

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::10382428f301a6e2b5d342e53b2a60dc
http://doc.rero.ch/record/299860/files/mdm111.pdf

Diffuse facial uptake on bone scintigraphy

Autor: Brans, B., Verzijlbergen, J.F.

Publikováno v: In Seminars in Nuclear Medicine 2000 30(1):70-73

Combining iodine-131 Lipiodol therapy with low-dose cisplatin as a radiosensitiser: preliminary results in hepatocellular carcinoma.

Autor: Brans, B., Van Laere, K., Gemmel, F., Defreyne, L., Vanlangenhove, P., Troisi, R., Van Vlierberghe, H., Colle, I., de Hemptinne, B., Dierckx, A.

Publikováno v: European Journal of Nuclear Medicine & Molecular Imaging. 2002, Vol. 29 Issue 7, p928. 5p.